Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hooper, R.
Right arrow Articles by Kearl, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hooper, R.
Right arrow Articles by Kearl, R.

Chest, Vol 97, 138-143, Copyright © 1990 by American College of Chest Physicians

ARTICLES

Established ARDS treated with a sustained course of adrenocortical steroids

RG Hooper and RA Kearl
Heart Lung Center, St. Lukes Medical Center, Phoenix.

Short treatment courses of ACS have been shown to be of no demonstrable value in the treatment of ARDS. We gave two patients with persistant ARDS a trial of ACS after they demonstrated pulmonary uptake of 67Ga. Brief initial improvement disappeared with tapering of the ACS. A sustained course of ACS led to resolution of the ARDS in both patients. In all, ten patients with established ARDS were treated with sustained ACS over an 18-month period. The eight additional patients had uninterrupted courses of therapeutic ACS for greater than 21 days. The patients averaged 12 days of greater than 40 mg a day. At the time of treatment, all patients had established ARDS, meeting for at least 72 hours, criteria for the diagnosis of ARDS. A sustained course of ACS may be effective in the treatment of selected patients with established ARDS. Controlled studies of established ARDS are indicated to define the characteristics of these patients and their management.


This article has been cited by other articles:


Home page
 NEJMHome page
P. Marik, S. Pastores, D. Annane, R. Speich, C. Schmid, R. Stocker, H. Okamoto, M. J. DiNubile, K. P. Steinberg, L. D. Hudson, et al.
Corticosteroids in ARDS.
N. Engl. J. Med., July 20, 2006; 355(3): 316 - 317.
[Full Text] [PDF]

Home page
 NEJMHome page
The National Heart, Lung, and Blood Institute Acut
Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome.
N. Engl. J. Med., April 20, 2006; 354(16): 1671 - 1684.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
G. R. Bernard
Acute Respiratory Distress Syndrome: A Historical Perspective
Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 798 - 806.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
J Cranshaw, M J D Griffiths, and T W Evans
The pulmonary physician in critical care c 9: Non-ventilatory strategies in ARDS
Thorax, September 1, 2002; 57(9): 823 - 829.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. A. JANTZ and S. A. SAHN
Corticosteroids in Acute Respiratory Failure
Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1079 - 1100.
[Full Text]

Home page
 JAMAHome page
G. U. Meduri, A. S. Headley, E. Golden, S. J. Carson, R. A. Umberger, T. Kelso, and E. A. Tolley
Effect of Prolonged Methylprednisolone Therapy in Unresolving Acute Respiratory Distress Syndrome: A Randomized Controlled Trial
JAMA, July 8, 1998; 280(2): 159 - 165.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
M. H. Kollef and D. P. Schuster
The Acute Respiratory Distress Syndrome
N. Engl. J. Med., January 5, 1995; 332(1): 27 - 37.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the American College of Chest Physicians.